UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

Journal of Neurochemistry
Helen C ArdleyPhilip A Robinson

Abstract

Aggresomes are associated with many neurodegenerative disorders, including Parkinson's disease, and polyglutamine disorders such as Huntington's disease. These inclusions commonly contain ubiquitylated proteins. The stage at which these proteins are ubiquitylated remains unclear. A malfunction of the ubiquitin/proteasome system (UPS) may be associated with their formation. Conversely, it may reflect an unsuccessful attempt by the cell to remove them. Previously, we demonstrated that overexpression of Parkin, a ubiquitin-protein ligase associated with autosomal recessive juvenile Parkinsonism, generates aggresome-like inclusions in UPS compromised cells. Mutations in the de-ubiquitylating enzyme, UCH-L1, cause a rare form of Parkinsonism. We now demonstrate that overexpression of UCH-L1 also forms ribbon-like aggresomes in response to proteasomal inhibition. Disease-associated mutations, which affect enzymatic activities, significantly increased the number of inclusions. UCH-L1 aggresomes co-localized with ubiquitylated proteins, HSP70, gamma-tubulin and, to a lesser extent, the 20S proteasome and the chaperone BiP. Similar to Parkin inclusions, we found UCH-L1 aggresomes to be surrounded by a tubulin rather than a vimentin cage...Continue Reading

Citations

Jul 15, 2009·Acta Neuropathologica·Norman L Lehman
Sep 10, 2011·Journal of Neural Transmission·Bokyung ParkYoung J Oh
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·D Allan ButterfieldTanea Reed
Mar 4, 2006·Journal of Proteome Research·Poonam SarkarGovindarajan T Ramesh
Apr 16, 2008·Human Molecular Genetics·Elli KyratziLeonidas Stefanis
Oct 16, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yan WangMichael Y Sherman
Nov 26, 2008·BMC Biochemistry·Shweta SinghalRohan T Baker
Jan 4, 2007·International Journal of Biological Sciences·Guang-Rui LuoWei-Dong Le
Jun 19, 2014·Current Neurology and Neuroscience Reports·Bruce J Brew, Phillip Chan
Oct 12, 2014·Neuromolecular Medicine·Kerry MooreFrancis O'Neill
Jul 14, 2009·Cellular and Molecular Life Sciences : CMLS·Yuko Hirota, Yoshitaka Tanaka
Jun 19, 2009·Journal of Neuropathology and Experimental Neurology·Elisa A WaxmanBenoit I Giasson
Jan 20, 2007·Cancer Science·Ashraf A Khalil, Peter James
Jun 30, 2006·Journal of Neurochemistry·Miratul M K MuqitDavid S Latchman
Apr 11, 2017·The Journal of Investigative Dermatology·Eun Young SeoJin Ho Chung
Sep 16, 2008·Biochimica Et Biophysica Acta·Brandi R WhatleyLih-Shen Chin
Jan 8, 2011·Neuro-degenerative Diseases·Paolo AridonGabriella Sconzo
Mar 18, 2011·Neuro-degenerative Diseases·Marie-Pierre HinaultPierre Goloubinoff
Mar 29, 2014·European Journal of Human Genetics : EJHG·Janine ScholefieldMatthew J A Wood
May 10, 2018·Clinical Science·Naomi C BoisvertChris R Kennedy
Jan 27, 2005·FEBS Letters·Helen C ArdleyPhilip A Robinson
Jul 1, 2009·Brain Pathology·Montse Olivé
Jul 29, 2010·Journal of Cellular Biochemistry·Huijuan WuZhigang Zhang
Apr 12, 2014·Journal of the American Society of Nephrology : JASN·Maire BeekenCatherine Meyer-Schwesinger
Dec 2, 2005·Journal of Neuropathology and Experimental Neurology·Ippolita Cantuti-CastelvetriDavid G Standaert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.